Cybin announces annual general and special shareholder meeting

PUBT · 2d ago
Cybin announces annual general and special shareholder meeting
  • Cybin shareholders meet virtually on Sept. 22, 2026 to review audited financial statements for the year ended March 31, 2026.
  • Vote on appointing Zeifmans as auditor for the next year.
  • Special resolutions seek to set the board at eight directors, elect eight directors, change the corporate name to Helus Pharma.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cybin Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001833141-26-000067), on August 19, 2026, and is solely responsible for the information contained therein.